TOP TIERMARKET NEWSWIRE
SEC Form 4 history

KEROS THERAPEUTICS I (KROS) insider trades

KEROS THERAPEUTICS I (KROS) insider trading activity (SEC Form 4). Over the trailing 90 days, KROS insiders filed 2 purchases totalling $21K and 4 sales totalling $101K — net SELLING of $80K. Most recent filing: Aug 20, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
2
$21K
Sells (90d)
4
$101K
Net (90d)
-$80K
net selling
Most recent
Aug 20, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 20, 2026Newton Charles W.DirS Sale—$10.30$6Kfiling
Aug 20, 2026Cho EstherGCS Sale—$10.29$46Kfiling
Aug 20, 2026Lerner Lorena RaquelChief Scientific OfficerS Sale—$10.29$37Kfiling
Aug 20, 2026Tanini AnnitaCorp. Controller, VP, FinanceS Sale—$10.29$13Kfiling
Aug 19, 2026Bienaime Jean JacquesDirP Purchase—$10.27$10Kfiling
Jul 17, 2026Bienaime Jean JacquesDirP Purchase—$10.61$11Kfiling
Jun 17, 2026Bienaime Jean JacquesDirP Purchase—$10.19$10Kfiling
Jun 15, 2026Newton Charles W.DirS Sale—$10.04$6Kfiling
Jun 8, 2026Knowles JuliusDirS Sale—$10.73$28Kfiling
Jun 8, 2026Farzan NimaDirS Sale—$10.73$28Kfiling
Jun 5, 2026Seth AlpnaDirS Sale—$10.72$28Kfiling
May 19, 2026Bienaime Jean JacquesDirP Purchase—$10.58$11Kfiling